Royce & Associates LP Teleflex Inc Transaction History

Royce & Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$229.54 - $275.63 $8.74 Million - $10.5 Million	-38,076 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$228.13 - $278.9 $433,447 - $529,910	-1,900 Reduced 4.75%	38,076 $10.1 Million
Q2 2018 Aug 09, 2018	SELL	$246.68 - $284.87 $616,700 - $712,175	-2,500 Reduced 5.89%	39,976 $10.7 Million
Q1 2018 May 14, 2018	SELL	$242.67 - $287.65 $19.7 Million - $23.3 Million	-80,998 Reduced 65.6%	42,476 $10.8 Million
Q4 2017 Feb 09, 2018	SELL	$236.76 - $270.19 $4.4 Million - $5.02 Million	-18,569 Reduced 13.07%	123,474 $30.7 Million
Q3 2017 Nov 13, 2017	SELL	$203.01 - $242.56 $1.22 Million - $1.46 Million	-6,007 Reduced 4.06%	142,043 $34.4 Million
Q2 2017 Aug 07, 2017	BUY	N/A	148,050	148,050 $30.8 Million

565

45.7M

18.3K

10.2K

Ticker TFX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,906,400
Market Cap $8.1B
Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.